Clinical Trial Update: Orthokeratology and 0.01% Atropine Sequential Treatment for Myopia Control [NA]

View source ↗

Summary

Clinical trial is recruiting to evaluate sequential treatment with orthokeratology and 0.01% atropine for myopia control.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Myopia

Drugs mentioned

• Atropine 0.01% ophthalmic solution (atropine)
• Orthokeratology lenses (orthokeratology)

Snippet

Sponsor: Zhongshan Ophthalmic Center, Sun Yat-sen University | Conditions: Myopia | NA | Status: RECRUITING